ClinicalTrials HQ

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

Active, not recruiting · NCT03741127 · Registry updated 2026-03-04
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 12026-03-04NCT03741127

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
California Institute for Regenerative Medicine (CIRM)36
Poseida Therapeutics, Inc.4

13 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Colorado Blood Cancer InstituteDenverUnited States178
Johns Hopkins UniversityBaltimoreUnited States60
MD Anderson Cancer CenterHoustonUnited States589
Sarah Cannon Research Institute at Tennessee OncologyNashvilleUnited States2
University of California DavisDavisUnited States2
University of California San FranciscoSan FranciscoUnited States144
University of California, San DiegoSan DiegoUnited States3
University of ChicagoChicagoUnited States312
University of Kansas Cancer CenterWestwoodUnited States36
University of Maryland Greenebaum Comprehensive Cancer CenterBaltimoreUnited States20
University of PennsylvaniaPhiladelphiaUnited States507
Vanderbilt University Medical CenterNashvilleUnited States40
Wayne State - Karmanos Cancer InstituteDetroitUnited States3